Skip to main content

Table 3 Direct and indirect costs applied in the base-case

From: Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran

Resource item

Lisdexamfetamine ($)

Methylphenidate ($)

Direct medical cost

Psychiatrist

23.55 (12.40–49.58)

34.43 (12.40–49.58)

Psychologist

17.22 (0–84.70)

34.69 (17.21–43.04)

Supplementary medicines

11.88 (6.20–24.79)

41.32 (4.13–123.96)

Medical tests

15.49 (1.03–41.32)

15.49 (1.03–41.32)

The total cost of outpatient services

6.89 (0–189.38)

6.89 (0–117.07)

The cost of the leading medicine

252.44 (139.88–365.00)

19.37 (8.89–40.00)

Direct non-medical cost

Intra-city transportation

9.74 (6.20–22.38)

19.63 (6.20–33.05)

Travel to and accommodation in the treatment city

110.18 (30.99–137.73)

84.36 (30.99–103.30)

Indirect cost

Salary of nurse/caregiver

17.22 (0–206.5)

8.61 (0–219.68)

Total patient costs (per 28 days)

464.61 (196.70–2979.88)

264.79 (80.85–434.25)